TAM (Treatments and Medicines) NHS Highland
Additions
*NEW* Formulary submissions (ratified at previous TAMSG)
- x
Minor additions
- x
Deletions
- x
Amendments
To view the changes, see the 'What's new' section.
These will be ratified at the next TAMSG.
Formulary updates
Additions
*NEW* Formulary submissions (ratified at previous TAMSG)
- Amivantamab concentrate for solution for infusion 350mg/7ml
- Durvalumab solution for infusion 50mg/ml (additional indication)
- Isatuximab concentrate for solution for infusion 20mg/ml (additional indication)
- Ribociclib tablets 200mg (additional indication)
- Tremlimumab concentrate for solution for infusion added (to be used in combination with durvalumab)
- Sunscreen lotion (Anthelios®) SPF 50+ 250mL
Minor additions
- Topical retinoids and related preparations for acne (Formulary: Dermatology) | Right Decisions
- Adapalene with benzoyl peroxide gel (Epiduo®) (adapalene 0·3%, benzoyl peroxide 2·5%)
- Leukotriene receptor antagonists (Formulary: Respiratory) | Right Decisions
- Montelukast 5mg chewable tablets
- Antiplatelets (Formulary: Cardiovascular) | Right Decisions
- Dipyridamole modified release capsules 200mg
- Ticagrelor capsules 90mg (off-label)
Deletions
- Benzoyl peroxide (Formulary: Dermatology) | Right Decisions
- Benzoyl peroxide aqueous gel 10% (discontinued)
- Wound management guidelines and formulary (Formularies) | Right Decisions
- Flamazine (silver sulfadiazine) 1% cream 50g tube (discontinued)
- Selective serotonin re-uptake inhibitors (SSRIs) (Formulary: CNS) | Right Decisions
- Paroxetine oral suspension 10mg/5mL (unlicensed and other licensed SSRI liquids are available)
- Prostate cancer: gonadorelin analogues, and gonadotrophin-releasing hormone antagonists (Formulary: Malignant disease) | Right Decisions
- Relugolix tablets 120mg (Formulary review)
Amendments
To view the changes, see the 'What's new' section.
- Alcohol dependence (Formulary: CNS) | Right Decisions (section review - already ratified)
- Respiratory syncytial virus (Formulary) | Right Decisions
- Devices for diabetes (Formularies) | Right Decisions
- Bipolar affective disorder (Formulary: CNS) | Right Decisions
- Tetracyclines (Formulary: Infections) | Right Decisions
- Other antibacterials (Formulary: Infections) | Right Decisions
- Oral preparations for acne (Formulary: Dermatology) | Right Decisions
- Benzoyl peroxide (Formulary: Dermatology) | Right Decisions
- Topical retinoids and related preparations for acne (Formulary: Dermatology) | Right Decisions
- Topical antibacterials for acne (Formulary: Dermatology) | Right Decisions
- Bisphosphonates used in malignant disease (Formulary: Endocrine) | Right Decisions
- Wound management guidelines and formulary (Formularies) | Right Decisions
- Topical NSAIDs and counter-irritants (Formulary) | Right Decisions
- Neuropathic pain (Formulary: CNS) | Right Decisions
- Midwife exemption formulary (Formularies) | Right Decisions
- Other vaginal infections (Formulary: Sexual Health) | Right Decisions
- Devices for respiratory conditions (Formulary: Respiratory) | Right Decisions
- Stimulant laxatives (Formulary: GI) | Right Decisions
- GP Out of Hours Formulary: Highland HSCP (Formularies) | Right Decisions
- Vaccines and antisera (Formulary: Immunology & Vaccines) | Right Decisions
- Sunscreen preparations (Formulary: Dermatology) | Right Decisions
- Oral potassium (Formulary) | Right Decisions
Additions
*NEW* Formulary submissions (ratified at previous TAMSG)
-
Thiamine solution for injection 50mg/mL (Licensed and Unlicensed preparations)
-
Buprenorphine oral lyophilisate tablet (Espranor®) 2mg, 8mg (Restricted: Specialist recommendation only (May ONLY be initiated in Primary Care under the recommendation of the Specialist))
-
Naloxone nasal spray unit dose 26mg/0.1mL
-
Naloxone nasal spray unit dose (Nyxoid®) 1.8mg/0.1mL
-
Nirsevimab solution for injection, pre-filled syringe (Beyfortus®) 100mg/mL, 50mg/0.5mL (Restricted: Hospital use only)
-
Belantamab mafodotin powder for concentrate for solution for infusion
-
Bevacizumab solution for infusion 25mg/mL (additional indications)
-
Blinatumomab powder for concentrate and solution for solution for infusion 38.5 micrograms
-
Durvalumab solution for infusion 50mg/ml (additional indication)
-
Fruquintinib capsules 1mg, 5mg
-
Nirsevimab solution for injection prefilled syringe 100mg/mL, 50mg/0.5mL
-
Rucaparib tablets 200mg, 250mg, 300mg (additional indication)
Additions
- GLP-1 RA & dual GIP/GLP-1 RA (Formulary: Endocrine) | Right Decisions
- Added: New formulation Rybelsus tablets (1.5mg. 4mg and 9mg strengths) with supporting information.
- Other antiemetics (Formulary: CNS) | Right Decisions
- Haloperidol: added oral liquid 5mg/5mL
- Chorea and tics (Formulary: CNS) | Right Decisions
- Haloperidol: added oral liquid 5mg/5mL
- First generation (Typical) antipsychotics (Formulary: CNS) | Right Decisions
- Haloperidol: added oral liquid 5mg/5mL
- Dementia (Formulary: CNS) | Right Decisions
- Rivastigmine: additional strength for the transdermal patch 13.3mg/24 hours
- Bisphosphonates used in osteoporosis (Formulary) | Right Decisions
- Ibandronic acid infusion 6mg/6mL (Restricted: Hospital use only)
Deletions:
- Other antiemetics (Formulary: CNS) | Right Decisions
- Haloperidol: removed oral liquid 2mg/mL and 10mg tablets
- Chorea and tics (Formulary: CNS) | Right Decisions
- Haloperidol: removed oral liquid 10mg/5mL and 10mg tablets
- First generation (Typical) antipsychotics (Formulary: CNS) | Right Decisions
- Haloperidol: removed oral liquid 2mg/mL and 10mg tablets
Minor amendments
To view the changes, see the 'What's new' section.
- Vaccines and antisera (Formulary) | Right Decisions
- Dementia (Formulary: CNS) | Right Decisions
- Bisphosphonates used in osteoporosis (Formulary) | Right Decisions
- Added: Ibandronic acid tablets 150mg
- Bisphosphonates used in malignant disease (Formulary) | Right Decisions
- Deleted: Ibandronic acid tablets 150mg
Additions
*NEW* Formulary submissions (ratified at previous TAMSG)
- Pravastatin tablets 10mg, 20mg, 40mg
- Ripretinib tablets 50mg
- Brentuximab vedotin powder for concentrate for solution for infusion 50mg (additional indication)
- Osimertinib tablets 40mg, 80mg (additional indication)
- Pembrolizumab concentrate 25mg/ml (additional indication)
- Selpercatinib capsules 40mg, 80mg (additional indication)
- Zanubrutinib hard-capsules 80mg (additional indication)
- Weak opioid analgesics (Formulary: CNS) | Right Decisions
- codeine syrup 15mg/5mL
- Wound management guidelines and formulary (Formularies) | Right Decisions
- 2 Layer Bandage System: UrgoKTwo Reduced compression 18 to 25 cm ankle (10cm)
- 2 Layer Bandage System: UrgoKTwo Reduced compression 25 to 32 cm ankle (10cm)
- Local corticosteroid injections (Formulary) | Right Decisions
- Dexamethasone injection (as sodium phosphate) 3·3mg/mL, 6·6mg/2mL
Deletions:
- Weak opioid analgesics (Formulary: CNS) | Right Decisions
- codeine syrup 25mg/5mL (discontinued)
- Specific drugs (Formulary: Poisoning) | Right Decisions
- Procyclidine solution for injection 10mg/2mL (discontinued)
- Antimuscarinics for extrapyramidal side-effects (Formulary: CNS) | Right Decisions
- Procyclidine solution for injection 10mg/2mL (discontinued)
- GP Out of Hours Formulary: Highland HSCP (Formularies) | Right Decisions
- Procyclidine solution for injection 10mg/2mL (discontinued)
- Anaphylaxis (Formulary) | Right Decisions
- Adrenaline/epinephrine (Emerade®) 500 micrograms pre-filled pen (discontinued)
- Local corticosteroid injections (Formulary) | Right Decisions
- Triamcinolone injection (as acetonide) (aqueous suspension) 40mg/mL (discontinued)
Minor amendments
To view the changes, see the 'What's new' section.
- Parenteral progestogen-only contraceptives (Formulary: Sexual health) | Right Decisions
- Midwife exemption formulary (Formularies) | Right Decisions
- Proton pump inhibitors (Formulary) | Right Decisions
- Devices for diabetes (Formularies) | Right Decisions
- Hypnotics (Formulary: CNS) | Right Decisions
- Aminosalicylates (Formulary) | Right Decisions
- Corticosteroid with antibacterial (Formulary) | Right Decisions
- Local corticosteroid injections (Formulary) | Right Decisions
New formulary entries
Formulary updates
To view the changes, see the 'What's new' section.
Formulary updates
To view the changes, see the 'What's new' section.
To view the changes, see the 'What's new' section.
Items will be added as they are published.
Additions:
Deletions:
- Diagnostic and monitoring devices for diabetes: CGM, BGM, Urinalysis
- Needles
Removed
- Guide to Highland Formulary inhaler devices (Formulary)
New ancillary formulary:
Ancillary formulary updates:
To view the changes to the formulary, see the 'What's new' section of each entry.
| Drug | Amendment | Date Formulary amended | Ratification date |
| July 2025 | |||
| Erdafitinib (Valversa®) film-coated tablets 3mg, 4mg, 5mg | Addition | 10/07/25 | 26/06/25 |
| FreeStyle Libre 3 and FreeStyle Libre 3 PLUS sensor kits | Addition | 24/07/25 | 28/08/25 |
| Nivolumab and Ipilimumab | Additional NCMAG indication | 10/07/25 | 26/06/25 |
| Pembrolizumab | Additional NCMAG indication | 10/07/25 | 26/06/25 |
| Ruxolitinib (Jakavi) tablets 5mg, 10mg, 15mg, 20mg | Additional SMC indication | 10/07/25 | 26/06/25 |
| Selpercatinib (Retsevmo) hard capsules 40mg, 80mg | Additional SMC indication | 10/07/25 | 26/06/25 |
| Ublituximab (Briumvi) concentrate for solution for infusion 25mg/mL | Addition | 10/07/25 | 26/06/25 |
| June 2025 | |||
| Calcium acetate (Renacet) tablets 475mg, 950mg | Addition | 04/06/25 | 26/06/25 |
| May 2025 | |||
| Bismuth subcitrate potassium/metronidazole/ tetracycline hydrochloride (Pylera) hard capsules | Addition | 01/05/25 | 24/04/25 |
| Budesonide/formoterol (Symbicort Turbohaler) 200 micrograms/6 micrograms/inhalation, inhalation powder | Addition | 01/05/25 | 24/04/25 |
| Fexofenadine hydrochloride tablets 120mg (generic) | Addition | 01/05/25 | 24/04/25 |
| Glycopyrronium with formoterol fumarate (Bevespi Aerosphere) 7.2micrograms/dose/ 5micrograms/dose pressurised inhaler | Addition | 01/05/25 | 24/04/25 |
| Idebenone (Raxone) 150mg film-coated tablets | Addition | 06/05/25 | 24/04/25 |
| April 2025 | |||
| Alectinib (Alecensa) capsules 150mg | Additional SMC indication | 29/04/25 | 24/04/25 |
| Beclometasone with formoterol Aerosol inhalation (Fostair) 200/6 micrograms | Addition | 04/04/25 | 24/04/25 |
| Cabozantinib (Cabozantinib Ipsen) film-coated tabs, 20mg, 40mg, 60mg | Additional SMC indication | 29/04/25 | 24/04/25 |
| Dalteparin solution for injection 2,500/0.2mL | Addition | 15/04/25 | 26/06/25 |
| Faricimab pre-filled syringes 120mg/mL (providing a dose of 6mg) | Addition | 07/04/25 | 24/04/25 |
| Futibatinib (Lytgobi) film-coated tablets | Addition | 29/04/25 | 24/04/25 |
| Latanoprost with timolol multidose 5mL and single dose 0.2mL preservative free | Addition | 04/04/25 | 24/04/25 |
| Mydricaine Solution for injection No2 0.3ml (unlicensed) | Moved from unlicensed list | 07/04/25 | 24/04/25 |
| Talazoparib (Talzenna) capsules 0.1mg, 0.25mg, 1mg | Additional SMC indication | 29/04/25 | 24/04/25 |
| March 2025 | |||
| Beclometasone with formoterol dry powder inhaler (Fostair NEXThaler) 200/6 micrograms | Addition | 20/03/25 | 24/04/25 |
| Cemiplimab concentrate for solution for infusion 350mg vial | Additional SMC indication | 05/03/25 | 27/02/25 |
| Dalteparin solution for injection 5,000/0.2mL, 7,500/0.3mL, 10,000/0.4mL, 12,500/0.5mL, 15,000/0.6mL, 18,000/0.72mL | Addition | 27/03/25 | 27/02/25 |
| Danicopan film-coated tablets 50mg, 100mg | Addition | 04/03/25 | 27/02/25 |
| Durvalumab concentrate for solution for infusion 50mg/ml | Additional SMC indication | 05/03/25 | 27/02/25 |
| Iptacopan capsules 200mg | Addition | 04/03/25 | 27/02/25 |
| Olaparib film-coated tablets 100mg, 150mg | Additional SMC indication | 04/03/25 | 27/02/25 |
| Sodium zirconium cyclosilicate powder for oral suspension 5g | Addition | 20/03/25 | 24/04/25 |
| Trametinib film-coated tablets 0.5mg, 2mg | Additional SMC indication | 04/03/25 | 27/02/25 |
| Drug | Amendment | Date formulary amended | Ratification date |
| December 2024 | |||
|
Alprep wound debridement pad 9cm x 7cm |
Addition | 20/12/24 | 27/02/25 |
|
Biatain Silicone 12.5 x 12.5cm (with border) |
Addition | 20/12/24 | 27/02/25 |
|
Cavilon Durable Barrier Cream 92g tube |
Addition | 20/12/24 | 27/02/25 |
|
Dorzolamide with timolol Preservative-free eye drops multidose 5mL (dorzolamide 2%, timolol 0·5%) |
Addition | 02/12/24 | 05/12/24 |
|
Ivermectin 3mg tablets |
Addition | 02/12/24 | 05/12/24 |
|
Polymem Non-adhesive 10 x 61cm |
Addition | 20/12/24 | 27/02/25 |
|
Quizartinib (Vanflyta) film-coated tablets |
Addition | 09/12/24 | 05/12/24 |
|
Spironolactone oral suspension 25mg/5ml |
Addition | 09/12/24 | 05/12/24 |
|
Tenecteplase (Metalyse) injection 25mg (5,000 units) |
Addition | 09/12/24 | 05/12/24 |
|
Varenicline 500 microgram, 1mg tablet |
Addition | 09/12/24 | 05/12/24 |
|
Zanubrutinib (Brukinsa) hard capsules |
Additional SMC indication | 09/12/24 | 05/12/24 |
| November 2024 | |||
| Aflibercept (Eylea) (30.1mg/263microlitres) 114.3mg/mL solution for intravitreal injection. Dose = 8mg in 70microlitres | Addition | 07/11/24 | 31/10/24 |
| Mavacamten (Camzyos) capsules | Addition | 08/11/24 | 31/10/24 |
|
Mucus clearance device (Aerobika) |
Addition | 07/11/24 | 31/10/24 |
| Pembrolizumab (Keytruda) 25mg/ml concentrate for solution for infusion (SMC2689) | Additional SMC indication | 05/11/24 | 31/10/24 |
| Relugolix (Orgovyx) 120mg film-coated tablets | Addition | 05/11/24 | 31/10/24 |
| Ritlecitinib (Litfulo) hard capsules 50mg | Addition | 07/11/24 | 31/10/24 |
| Selinexor (Nexpovio) 20mg film-coated tablets | Addition | 05/11/24 | 31/10/24 |
| Trifluridine tipiracil (Lonsurf) film-coated tablets, 15mg/6.14mg, 20mg/8.19mg | Addition | 05/11/24 | 31/10/24 |
| September 2024 | |||
|
Adalimumab solution for injection, pre-filled syringe (Amgevita) 20mg/0·4mL, 40mg/0·8mL, solution for injection, pre-filled syringe (Humira) 40mg/0·4mL, solution for injection, pre-filled pen (Amgevita) 40mg/0·8mL and solution for injection, pre-filled pen (Humira) 40mg/0·4mL |
Addition | 11/09/24 | 31/10/24 |
| Buprenorphine (50mg/mL): 8mg, 16mg, 24mg, 32mg prolonged release solution for injection pre-filled syringes (terminal half-life ranging from 3 to 5 days) | Addition | 05/09/24 | 29/08/24 |
| Buprenorphine (355.56mg/mL): 64mg, 96mg, 128mg prolonged release solution for injection pre-filled syringes (terminal half-life ranging from 19 to 25 days) | Addition | 05/09/24 | 29/08/24 |
| Elranatamab solution for injection 40mg/ml | Addition | 11/09/24 | 29/08/24 |
|
Hydroxyzine 10mg/5mL syrup discontinued - amend to Oral syrup 10mg/5mL unlicensed |
Amendment | 13/09/24 | 31/10/24 |
| Ivacaftor with tezacaftor and elexacaftor tablets (Kaftrio®) 37.5mg/25mg/50mg, 75mg/50mg/100mg and granules in sachet (Kaftrio®) 60mg/40mg/80mg, 75mg/50mg/100mg | Addition | 05/09/24 | 29/08/24 |
| Lumacaftor with ivacaftor tablets (Orkambi®) 100mg/125mg, 200mg/125mg andgranules in sachet (Orkambi®) 75mg/94mg, 100mg/125mg, 150mg/188mg | Addition | 05/09/24 | 29/08/24 |
|
Methylphenidate modified release - remove brands |
Amendment | 18/09/24 | 31/10/24 |
| Nivolumab with relatlimab concentrate for solution for infusion | Addition | 05/09/24 | 29/08/24 |
| Pembrolizumab concentrate for solution for infusion 25mg/mL | Addition | 05/09/24 | 29/08/24 |
|
Secukinumab solution for injection in pre-filled pen 150mg, 300mg and solution for injection in pre-filled syringe 150mg, 300mg |
Addition | 11/09/24 | 31/10/24 |
| Teclistamab solution for injection 10mg/ml | Addition | 11/09/24 | 29/08/24 |
| Tezacaftor with ivacaftor tablets (Symkevi®) 50mg/75mg, 100mg/150mg | Addition | 05/09/24 | 29/08/24 |
| Vitamin B complex, Vitamin B compound strong tablets nicotinamide 20mg, pyridoxine hydrochloride 2mg, riboflavin 2mg, thiamine hydrochloride 5mg | Addition | 05/09/24 | 29/08/24 |
| August 2024 | |||
| ActiForm Cool hydrogel 10cm x 15cm | Addition | 13/08/24 | 29/08/24 |
| July 2024 | |||
| Acetylycysteine effervescent tablets 600mg | Addition | 04/07/24 | 27/06/24 |
| Bimekizumab 160mg solution for injection in pre-filled syringe and pre-filled pen | Addition | 04/07/24 | 27/06/24 |
| Epcoritamab 48mg solution for injection and 4mg/0.8ml concentrate for solution for injection | Addition | 04/07/24 | 27/06/24 |
| Glofitamab 10mg, 2.5mg concentrate for solution for infusion | Addition | 04/07/24 | 27/06/24 |
| Hydrogen peroxide cream 1% 25g tube | Addition | 05/07/24 | 27/06/24 |
| Linaclotide 290 microgram capsule | Addition | 04/07/24 | 27/06/24 |
| Momelotinib 100mg, 150mg, 200mg film coated tablets | Addition | 04/07/24 | 27/06/24 |
| Naldemedine 200 microgram film-coated tablets | Addition | 04/07/24 | 27/06/24 |
| Tirzepatide KwikPen 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg solution for injection in prefilled pen | Addition | 04/07/24 | 27/06/24 |
| May 2024 | |||
| Bimekizumab solution for injection in pre-filled syringe and pre-filled pen | Addition | 03/05/24 | 25/04/24 |
| Daratumumab 20mg/mL concentrate for solution for infusion | Addition | 03/05/24 | 25/04/24 |
| Dostarlimab 500mg concentrate for solution for infusion (SMC2635) | Additional SMC indication | 03/05/24 | 25/04/24 |
| Finerenone 10mg, 20mg tablets | Addition | 03/05/24 | 25/04/24 |
| Ivosidenib 250mg film-coated tablets (SMC2615) | Addition | 03/05/24 | 25/04/24 |
| Loncastuximab tesirine 10mg powder for concentrate for solution of infusion (SMC2609) | Addition | 03/05/24 | 25/04/24 |
| Olaparib 100mg, 150mg tablets (SMC2617) | Additional SMC indication | 03/05/24 | 25/04/24 |
| Roxadustat 20mg, 50mg, 70mg, 100mg, 150mg tablets | Addition | 03/05/24 | 25/04/24 |
| Secukinumab solution for injection in pre-filled pen 150mg, 300mg and solution for injection in pre-filled syringe 150mg, 300mg | Addition | 11/09/24 | to go to 31/10/24 |
| Talazoparib 0.25mg, 1mg capsules (SMC2607) | Addition | 03/05/24 | 25/04/24 |
| Vortioxetine 5mg, 10mg, 20mg tablets | Addition | 03/05/24 | 25/04/24 |
| April 2024 | |||
| Atogepant 10mg, 60mg tablets | Addition | 22/04/24 | 29/02/24 |
| Dexcom One+ | Addition | 30/04/24 | 25/04/24 |
| Freestyle Libre 2 Plus | Addition | 30/04/24 | 25/04/24 |
| Nicotine - Lozenge mini (Niquitin Minis Lozenge®) 2mg | Addition | 19/04/24 | 27/06/24 |
| Rimegepant oral lyophilisate 75mg | Addition | 22/04/24 | 29/02/24 |
| March 2024 | |||
| Buprenorphine with naloxone 16mg/4mg sublingual tablets | Addition | 04/03/24 | 29/02/24 |
| FreeStyle Libre 3 rt-CGM (real time continuous glucose monitoring system) | Addition | 04/03/24 | 29/02/24 |
| Lurasidone 18.5mg, 37mg, 74mg film-coated tablets | Addition | 11/03/24 | 29/02/24 |
| Nivolumab 10mg/ml concentrate for solution for infusion (SMC2619) | Additional SMC indication | 05/03/24 | 29/02/24 |
| Pembrolizumab 25mg/ml concentrate for solution for infusion (SMC2589) | Additional SMC indication | 05/03/24 | 29/02/24 |
| Prucalopride tablets 2mg | Addition | 27/03/24 | 29/02/24 |
| Tafamidis capsules 61mg | Addition | 13/03/24 | 29/02/24 |
| Trastuzumab deruxtecan 100mg powder for concentrate for solution for infusion (SMC2608) | Additional SMC indication | 05/03/24 | 29/02/24 |
| February 2024 | |||
| Acalabrutinib 100mg tablets | Addition | 09/02/24 | 29/02/24 |
| January 2024 | |||
| Iloprost 50microgram/0.5m concentrate for solution for infusion ampoules | Addition | 29/01/24 | 29/02/24 |
| Drug | Amendment | Date formulary amended | Ratification date |
| December 2023 | |||
| Aviptadil with phentolamine mesilate 25 micrograms/2mg in 0.35ml solution for injection SMC1284/17 | Addition | 22/12/23 | 07/12/23 |
| Durvalumab 50mg/ml solution for infusion SMC2582 | Additional SMC indication | 12/12/23 | 07/12/23 |
| Emollin aerosol spray | Addition | 12/12/23 | 07/12/23 |
| Eptinezumab 100mg concentrate for solution for infusion SMC2547 | Addition | 12/12/23 | 07/12/23 |
| Formoterol fumarate with glycopyrronium and budesonide 5mcg/7.2mcg/160mcg pressurised inhalation, suspension (Trixeo® Aerosphere) SMC2321 | Addition | 22/12/23 | 07/12/23 |
| Ozanimod 0.23mg, 0.46mg and 0.92mg hard capsules SMC2478 | Addition | 12/12/23 | 07/12/23 |
| Risankizumab 600mg/10mL concentrate for solution for infusion vial and 360mg/2.4mL solution for injection cartridge SMC2534 | Addition | 12/12/23 | 07/12/23 |
| Selpercatinib 40mg and 80mg capsules SMC2573 | Additional SMC indication | 12/12/23 | 07/12/23 |
| November 2023 | |||
| Aprostadil urethral stick 500, 1000 microgram | Addition | 22/11/23 | 07/12/23 |
| Atezolizumab 1,875mg/15mL (125mg/mL) solution for injection (subcutaneous) | Addition (new formulation) | 10/11/23 | 07/12/23 |
| Lanreotide ipsen | Name change - previously called Somatuline Autogel | 13/11/23 | 07/12/23 |
| Risankizumab 150mg/mL pre-filled pen and pre-filled syringe SMC2196 | Addition | 21/11/23 | 07/12/23 |
| October 2023 | |||
| Cenobamate tablets SMC2408 | Addition | 31/10/23 | 26/10/23 |
| DRUG | REASON FOR DELETION | SUBGROUP MEETING |
| Acalabrutinib capsules | discontinued - use tablets | February 2024 |
| Acetic acid spray 2% | discontinued | August 2019 |
| Aciclovir eye ointment 3% (Zovirax®) | discontinued | January 2019 |
| ActiForm Cool hydrogel 5cm x 6.5cm | discontinued | February 2025 |
| ActiForm Cool hydrogel 10cm x 15cm | discontinued | February 2025 |
| ActiForm Cool hydrogel 10cm x 10cm | No longer used in NTC. | August 2024 |
| Adrenaline/epinephrine injection 1 in 1,000: disposable syringe 1mg/mL (Minijet®) | discontinued - use 1 in 1,000 solution for injection pre-filled syringe (1mg/mL) instead. | April 2024 |
| Adrenaline/epinephrine injection 1 in 10,000 1mg/10mL (Minijet®) | discontinued - use 1 in 10,000 dilute solution for injection pre-filled syringe (1mg/10mL) instead. | April 2024 |
| Alphosyl shampoo | discontinued | February 2023 |
| Alprostadil 250 microgram urethral application (MUSE®) | discontinued | April 2020 |
| Apomorphine solution for injection 20mg/2mL | discontinued | August 2025 |
| Apomorphine solution for infusion, pre-filled syringe 50mg/10mL | February 2025 | |
| Beclometasone dipropionate Qvar Easibreathe inhaler | Formulary review | April 2025 |
| Betamethasone 0.1% eye ointment | discontinued | April 2020 |
| Biphasic Isophane insulin Injection 25% soluble, 75% isophane 100 units/mL 3mL cartridge (Insuman® Comb 25 for ClikSTAR®, Autopen®) and 3mL pre-filled pen (Insuman Comb 25 SoloStar®) | discontinued | February 2023 |
| Biphasic Isophane insulin Injection 50% soluble, 50% isophane 100 units/mL and 3mL cartridge (Insuman® Comb 50 for ClikSTAR®, Autopen®) | discontinued | February 2023 |
| Buprenorphine with naloxone film, all strengths | discontinued | February 2024 |
| Calcium syrup (calcium 2·5mmol or 102mg/5mL) unlicensed | discontinued | October 2022 |
| Calcium acetate (Phosex) tablets 1 gram (calcium 250mg or 6.2mmol/tablet) | discontinued | June 2025 |
| Calcium polystyrene sulphonate powder (Calcium Resonium) | UKKA Oct 23: no role for Ca resonium for acute hyperkalaemia | December 2024 |
| Cervarix vaccine suspension for injection 0.5ml pre-filled syringes | discontinued | June 2021 |
| Ciprofloxacin 3mg/mL, dexamethasone 1mg/mL (Cilodex) ear drops | discontinued | April 2021 |
| Clozapine oral suspension 50mg/ml | Formulary review; use 25mg and 100mg orodisperisble tablets | April 2022 |
| Collagenase | discontinued | December 2020 |
| Cyclo-progynova 2mg tablets | discontinued | April 2020 |
| Daclatasvir 30mg and 60mg tablets | discontinued | November 2019 |
| Dasabuvir 250mg tablets | discontinued | February 2021 |
| Deferiprone 500mg tablets | discontinued | November 2019 |
| Dermamist 10% spray | discontinued | October 2022 |
| Desflurane Inhalation vapour 1mL/1mL | No longer used | February 2022 |
| Dexamethasone soluble tablets 2mg, 4mg, 8mg | Formulary review; standard tablets can be dispersed in water | December 2021 |
| Diazepam emulsion for injection 10mg/2mL | Discontinued - no replacement identified (solution for injection not used at Raigmore). | August 2024 |
| Diazepam rectal solution tubes 2.5mg/1.25mL | removed due to unavailability | December 2021 |
| Dicobalt Edetate 300mg/20mL injection | discontinued - replaced with Sodium nitrite solution for injection | May 2020 |
| Dihydrocodeine 10mg/5ml oral solution | discontinued | February 2021 |
| Diprobase cream and ointment | Formulary review; Zeroderma range first line choice | February 2021 |
| Dithranol (Dithrocream) 2% cream | discontinued | April 2021 |
| Dithranol (Dithrocream®) 0.25%, 0.5% and 1% cream | discontinued | April 2022 |
| Doublebase® Gel | replaced with Zerodouble® Emollient Gel | January 2019 |
| Engerix B 20microgram/1mL | discontinued | April 2021 |
| Enzalutamide 40mg capsules | discontinued - replaced with enzalutamide tablets | April 2020 |
| Epaderm ointment | Formulary review, Zeroderma range first line choice | February 2021 |
| Estradiol (Vagifem) | Vagirux preferred brand for environmental reasons | October 2021 |
| Ethinylestadiol and norethisterone (Loestrin) 20 and 30 tablets | discontinued | October 2019 |
| Exenatide injection, pre-filled pen 5 micrograms/dose, 10 micrograms/dose and prolonged-release suspension for injection 2mg/pre-filled pen | discontinued | April 2024 |
| Exenatide modified release powder for reconstitution 2mg/pre-filled pen | discontinued - use prolonged-release suspension for injection 2mg/pre-filled pens | October 2022 |
| Flecainide 200mg modified release tablets | discontinued | April 2020 |
| Fluocinolone acetonide cream (Synalar 1 in 4 Dilution®) 0·00625% | discontinued | April 2025 |
| Fluphenazine decanoate solution for injection (oily) 12.5g/0.5mL, 25mg/1mL 100mg/1mL | discontinued | August 2021 |
| Fluticasone propionate/ formoterol 125 microgram/5 microgram (Flutiform® K-haler®) | discontinued | April 2021 |
| Fluticasone with formoterol inhaler 50/5micrograms/dose, 125/5micrograms/dose and 250/10micrograms/dose (Flutiform®) | Formulary review - not used in asthma | April 2025 |
| Fluticasone with salmeterol dry powder for inhalation disk containing blisters of 100/50, 250/50, 500/50 (in micrograms)/blister (Seretide® Accuhaler®) | Formulary review | April 2025 |
| Gynest 0.01% estriol | Formulary review - estriol cream of choice: estriol 0.1% | August 2020 |
| Haloperidol 500 microgram capsules | discontinued | April 2020 |
| Hep A + Typhoid (viatim) | discontinued | April 2024 |
| Human papillomavirus (type 16, 18) vaccine (absorbed) suspension for injection 0.5ml pre-filled syringes | discontinued | June 2021 |
| Hydrocortisone 10% rectal foam | discontinued | April 2020 |
| Hydrocortisone (as acetate) (aqueous suspension) 25mg/1mL injection | discontinued | April 2022 |
| Ibandronic acid infusion 2mg/2mL and 6mg/6mL | no longer used for malignant disease | May 2019 |
| Infliximab powder for concentrate for solution for infusion 100mg (Remicade®) | Formulary review - Remsima should be used | June 2021 |
| Infliximab powder for concentrate for solution for infusion 100mg | Formulary review - Inflectra, Remsima and Zessly brands should be used | April 2022 |
| Insulin detemir (Levemir InnoLet) 100 units/ml solution for injection 3ml pre-filled pens | discontinued | August 2025 |
| Insulin glargine injection 100 units/mL 3mL cartridge (Abasaglar® for Autopen®) and (Lantus for ClikSTAR, Autopen®24) | discontinued | February 2023 |
| Insuman Comb 25 100units/ml suspension for injection 5ml vials | discontinued | June 2021 |
| Irriclens 240ml aerosol | Not used in Highland | October 2024 |
| Isophane insulin 100 units/mL 5mL vial (Insuman® Basal) injection | discontinued | April 2022 |
| Isophane insulin (Insulatard InnoLet) 100units/ml suspension for injection 3ml pre-filled pens | discontinued | August 2025 |
| Isophane insulin 10mL vial (Insulatard®), removed 3mL cartridge (Insuman® Basal for ClikSTAR, Autopen®), (Humulin I® for Autopen®) and 3mL pre-filled pen (Insuman Basal SoloStar®) | discontinued | February 2023 |
| Isoprenalin injection 2mg/2mL unlicensed (hospital use only) | Use licensed version | April 2022 |
| Liraglutide injection, pre-filled pen 18mg/3mL | Formulary review - semaglutide put as first line. | June 2025 |
| Macrogol 3350 with anhydrous sodium sulfate, potassium chloride, sodium bicarbonate and sodium chloride (Vista-Prep®) | discontinued | August 2024 |
| Macrogol 3350 with anhydrous sodium sulfate, potassium chloride, sodium bicarbonate and sodium chloride (Klean-prep®) | Discontinued. NB - to remain on Formulary until stock is used up. | August 2024 |
| Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride (Klean-Prep) oral powder 69g/sachet | Formulary review - VistaPrep should be used | October 2021 |
| Magnesium hydroxide Mixture BP | alternative products available | December 2020 |
| Mannitol (Viaflex®) | discontinued | August 2019 |
| Mepolizumab power for solution for injection vials | discontinued | October 2024 |
| Mesalazine 400mg and 800mg (Asacol® brand only) | May 2019 | |
| Mesalazine foam enema (Asacol®) | discontinued | October 2021 |
| Methotrexate subcutaneous all strengths (Zlatal® brand only) | Formulary review - Methofill should be used | December 2020 |
| Nepafenac 1mg/ml eye drops | Replaced by nepafenac 3mg/ml eye drops | June 2021 |
| Nicotine - Lozenge mini (Niquitin Minis Lozenge®) 1.5mg | Discontinued - use 2mg | June 2024 |
| Norethisterone acetate and ethinylestradiol (Loestrin®) | discontinued | November 2019 |
| Ofatumumab concentrate for solution for infusion 20mg/mL | discontinued | February 2021 |
| Orlistat capsules | No longer recommended by NHS Highland. See the NHS Highland Adult Healthy Weight pathway. | January 2019 |
| Pembrolizumab 50mg powder for infusion | discontinued | June 2022 |
| Phytomenadione | Konakion brand discontinued | February 2025 |
| Pirfenidone 267mg capsules | discontinued - use tablets | June 2022 |
| Pralsetinib hard capsules 100mg | discontinued | October 2024 |
| Prazosin 1mg tablets | discontinued | April 2022 |
| Prednisolone retention enema 20mg/100mL | discontinued | August 2019 |
| Prednisolone foam enema 20mg/metered application (as metasulfobenzoate sodium) | Formulary review - budesonide rectal foam 2mg/dose should be used | February 2022 |
| Ranitidine 75mg/5ml oral solution sugar free | discontinued | June 2021 |
| Ranitidine 150mg and 300mg effervescent tablets | discontinued | June 2021 |
| Ranitidine 150mg and 300mg tablets | discontinued | February 2022 |
| Risankizumab 75mg/0.83mL | discontinued - alternative is 150mg/mL pre-filled pen and pre-filled syringe | December 2023 |
| Salbutamol, Salamol 100micrograms/dose Easi-Breathe inhaler (MDI) | Formulary review | April 2025 |
| Selegeline oral lyophilisate tablet 1.25mg | discontinued | December 2020 |
| Simeprevir capsules 150mg | discontinued | February 2021 |
| Sitagliptin 25mg, 50mg and 100mg tablets | replaced with alogliptin | August 2019 |
| Sodium aurothiomalate 10mg/0∙5ml and 50mg/0∙5ml injection | discontinued | August 2021 |
| Sodium chloride 4∙5% eye drops | discontinued - replaced by sodium chloride 5% preservative free eye drops | August 2021 |
| Sodium fusidate tablets 250mg and oral suspension (as fusidic acid) 250mg/5mL | discontinue | August 2025 |
| Somatropin (Norditropin Simplexx®) 5mg/1∙5ml, 10mg/1∙5ml and 15mg/1∙5ml solution for injection | replaced with Norditropin Flexpro | August 2021 |
| Theophylline (Slo-Phyllin®) 60mg, 125mg and 250mg | discontinued | February 2020 |
| Tolterodine 1mg and 2mg tablets and 4mg modified release | replaced with solifenacin | April 2020 |
| Triamcinolone acetonide 10mg/1ml suspension for injection ampoules | discontinued | February 2021 |
| Ulipristal acetate (Esmya) 5mg tablets | discontinued | April 2021 |
| Varenicline tablets 500 microgram, 1mg, starter pack | discontinued | October 2022 |
| Viekirax 12.5mg, 50mg and 75mg tablets | discontinued | February 2021 |
| VitA-POS eye ointment preservative free | discontinued - replaced with Hylo Night | August 2021 |
| Xerotin® oral spray | not available | January 2019 |
Central Alerting System provides links to:
- National Patient Safety Alerts
- Department of Health and Social Care
- Medicines and Healthcare products Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Medical devices regulation and safety
- Latest information for patients
- MHRA guidance on coronavirus (COVID-19)
- About MHRA
- All MHRA services and information
- NHS England
- UKHSA
Additions
*NEW* Formulary submissions
- These will be added as published
Deletions:
- These will be added as removed
Amendments:
To view the changes, see the 'What's new' section.
These will be ratified at the next TAMSG.
- These will be added as published